Rapibloc 300 mg, Pulver zur Herstellung einer Infusionslösung
7680686110014
CH-68611
Pulver
Associated product:
RAPIBLOC subst sèche 300 mg 1 flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
landiololi hydrochloridum
|
300.0 MG | Substance | WIZUS |
|
landiololum
|
280.0 MG | Substance | Wirkstoff (Principe actif) |
|
mannitolum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Authorization holder
OrPha Swiss GmbH
8700 Küsnacht ZH
Authorization information
- Swissmedic authorization number
- 68611
- Drug name
- Rapibloc, Pulver zur Herstellung einer Infusionslösung
- Galenic form
- PULVI
- ATC Code
- C07AB14
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 19/10/2022
- Authorization expiration date
- 18/10/2027
- IT Number
- 02.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- RAPIBLOC subst sèche 300 mg 1 flac
- Description (DE)
- RAPIBLOC Trockensub 300 mg 1 Durchstf
- Market launch
- 19/10/2022
- Narcotic (BTM)
- No